Unpublished conference/Abstract (Scientific congresses and symposiums)
Everolimus (EVE) plus exemestane (EXE) in elderly patients (pts) with hormone receptor-positive (HR+), human epidermal growth receptor-2 negative (HER2-) advanced breast cancer (ABC) progressing on prior nonsteroidal aromatase inhibitors (NSAIs) : Insights on safety from BALLET (CRAD001YIC04)
Neven, P.; Generali, D.; Ciruelos, E.M. et al.
2016Miami Breast Cancer Conference
 

Files


Full Text
Everolimus (EVE) plus Exemestane (EXE) in elderly patients (pts) with hormone ... - abstract.pdf
Publisher postprint (211.43 kB)
Request a copy
Annexes
Everolimus (EVE) plus Exemestane (EXE) in elderly patients (pts) with hormone ... - poster.pdf
Publisher postprint (317.16 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
oncology
Disciplines :
Oncology
Author, co-author :
Neven, P.
Generali, D.
Ciruelos, E.M.
Lang, I.
Gavila, J.
Bighin, C.
Borms, M.
Conte, P.
Montemurro, F.
Sartori, D.
Marini, L.
Camozzi, M.
Lorizzo, K.
Ocak, O.
JERUSALEM, Guy  ;  Centre Hospitalier Universitaire de Liège - CHU > Service d'oncologie médicale
More authors (5 more) Less
Language :
English
Title :
Everolimus (EVE) plus exemestane (EXE) in elderly patients (pts) with hormone receptor-positive (HR+), human epidermal growth receptor-2 negative (HER2-) advanced breast cancer (ABC) progressing on prior nonsteroidal aromatase inhibitors (NSAIs) : Insights on safety from BALLET (CRAD001YIC04)
Publication date :
2016
Event name :
Miami Breast Cancer Conference
Event place :
Miami, United States
Event date :
March 10-13, 2016
Audience :
International
References of the abstract :
350
Available on ORBi :
since 05 July 2016

Statistics


Number of views
39 (0 by ULiège)
Number of downloads
0 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi